Drug Trial Radar · NCT07432958
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Last checked: Nov 19, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Feb 25, 2026
Primary completion
Sep 3, 2027
Study completion Jan 3, 2028
Sponsor
- Lead sponsor
- Appello Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 25, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 30 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2 study in people with Parkinson's disease who experience motor fluctuations while taking levodopa. The study will evaluate how effective two different doses of the study drug AP-472 are when added to levodopa treatment, compared with a placebo. The study will last about 14 weeks. Participants will be randomly assigned to receive one of the two doses of AP-472 or a placebo. Neither the participants nor the study staff will know which treatment is given. The study includes a screening period, a 4-week period during which Parkinson's medications must remain stable, and a 12-week treatment period. During the treatment period, limited adjustments to levodopa are allowed if needed.
Conditions
- Parkinson Disease
Interventions
AP-472Drug
Oral tablet
PlaceboOther
Oral tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in average daily OFF time on motor diaries for AP-472 compared to placebo (normalized to 16-hour awake time)Time frame: Week 12
Locations
30 sites in 1 country. Site status is shown where the registry gives one.
University of Arkansas for Medical Sciences (Site #208)
Little Rock, Arkansas · Recruiting
Profound Research LLC (Site #222)
Carlsbad, California · Recruiting
Collaborative Neuroscience Network - Los Alamitos- CenExel - PPDS (Site #217)
Los Alamitos, California · Recruiting
Keck Medicine of USC - USC Healthcare Center 2 (Site #221)
Los Angeles, California · Recruiting
Parkinson's Research Centers of America (Site #218)
Palo Alto, California · Recruiting
Rocky Mountain Clinical Research - CenExel - PPDS (Site #215)
Englewood, Colorado · Recruiting
Parkinson's Disease & Movement Disorders Center of Boca Raton (Site #227)
Boca Raton, Florida · Recruiting
UM-UHealth at Boca Raton (Site #226)
Boca Raton, Florida · Recruiting
Velocity Clinical Research - Hallandale Beach (Site #228)
Hallandale, Florida · Recruiting
University of Miami (Site #220)
Miami, Florida · Recruiting
Neurology One (Site #205)
Orlando, Florida · Recruiting
USF Parkinson's Disease and Movement Disorders Center (Site #206)
Tampa, Florida · Recruiting
Augusta University Medical Center (Site #212)
Augusta, Georgia · Recruiting
Josephson Wallack Munshower Neurology PC (Site #231)
Indianapolis, Indiana · Recruiting
The University of Kansas (KU) (Site #216)
Kansas City, Kansas · Recruiting
Kentucky Neuroscience Institute (Site #213)
Lexington, Kentucky · Recruiting
Beth Israel Deaconess Medical Center (Site #211)
Boston, Massachusetts · Recruiting
University of Michigan Health System (UMHS) (Site #202)
Ann Arbor, Michigan · Recruiting
Quest Research Institute - Alcanza - PPDS (Site #201)
Farmington Hills, Michigan · Recruiting
University of New Mexico Health Sciences Center (Site #225)
Albuquerque, New Mexico · Recruiting
Joan and Sanford I. Weill Department of Medicine (Site #224)
New York, New York · Recruiting
Mount Sinai School of Medicine (Site #209)
New York, New York · Recruiting
Asheville Neurology Specialists, P.A. (Site #229)
Asheville, North Carolina · Recruiting
Duke Neurological Disorders Clinic (Site #210)
Durham, North Carolina · Recruiting
Cleveland Clinic (Site #223)
Cleveland, Ohio · Recruiting
The Ohio State University Wexner Medical Center (site #207)
Columbus, Ohio · Recruiting
Vanderbilt University Medical Center (Site #204)
Nashville, Tennessee · Recruiting
Horizon Clinical Research: Gill Neuroscience - Houston (Site #232)
Cypress, Texas · Recruiting
Central Texas Neurology Consultants (Site #203)
Round Rock, Texas · Recruiting
EvergreenHealth (Site #219)
Kirkland, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.